Abstract
The synthesis of two derivatives of lignan 4'-O-methylhonokiol (MH), i.e., 4'-methoxy-5-propyl-1,1'-biphenyl-2-ol (III) and 4'-(2-fluoroethoxy)-2-hydroxy-5-propyl-1,1'-biphenyl (VI) has been described. Derivative (VI) demonstrates the highest anti-inflammatory activity in the lipopolysaccharide-induced (LPS-induced) neuroinflammation mouse model. Its effect on the morphological changes in the brain is comparable to that of celecoxib, a well-known nonsteroid anti-inflammatory drug and a selective inhibitor of cyclooxygenase-2 (COX 2).
Similar content being viewed by others
REFERENCES
Perry, V., Nicoll, J., and Holmes, C., Nat. Rev. Neurol., 2010, vol. 6, pp. 193–201.
Prata, J., Santos, S., Almeida, M., Coelho, R., and Barbosa, M.A., J. Neuroinflammation, 2017, vol. 14, pp. 179–212.
Jacobs, A.H. and Tavitian, B., J. Cereb. Blood Flow Metab., 2012, vol. 32, pp. 1393–1415.
Ory, D., Celen, S., Verbruggen, A., and Bormans, G., Curr. Pharm. Des., 2014, vol. 20, pp. 5897–5913.
Laube, M., Kniess, T., and Pietzsch, J., Molecules, 2013, vol. 18, pp. 6311–6355.
Rayar, A.M., Lagarde, N., Ferroud, C., Zagury, J.-F., Montes, M., and Veitia, M.S.-I., Curr. Top. Med. Chem., 2017, vol. 17, pp. 2935–2956.
Yuan, Y., Subedi, L., Lim, D., Jung, J.K., Kim, S.Y., and Seo, S.Y., Bioorg. Med. Chem. Lett., 2019, vol. 29, pp. 3329–3339.
Kim, H.S., Ryu, H.S., Kim, J.S., Kim, Y.G., Lee, H.K., Jung, J.K., Kwak, Y.S., Lee, K., Seo, S.Y., Yun, J., Kang, J.S., Hong, J.T., Kim, Y., and Han, S.-B., Arch. Pharm. Res., 2015, vol. 38, pp. 813–825.
Penning, T.D., Talley, J.J., Bertenshaw, S.R., Carter, J.S., Collins, P.W., Docter, S., Graneto, M.J., Lee, L.F., Malecha, J.W., Miyashiro, J.M., Rogers, R.S., Rogier, D.J., Yu, S.S., Anderson, G.D., Burton, E.G., Cogburn, J.N., Gregory, S.A., Koboldt, C.M., Perkins, W.E., Seibert, K., Veenhuizen, A.W., Zhang, Y.Y., and Isakson, P.C., J. Med. Chem., 1997, vol. 40, pp. 1347–1365.
Lee, B., Kwak, J.-H., Huang, S.-W., Jang, J.Y., Lim, S., Kwak, Y.S., Lee, K., Kim, H.S., Han, S.B., Hong, J.T., Lee, H., Song, S., Seo, S.Y., and Jung, J.K., Bioorg. Med. Chem., 2012, vol. 20, pp. 2860–2868.
Zhang, P., Liu, X., Zhu, Y., Chen, S., Zhou, D., and Wang, Y., Neurosci. Lett., 2013, vol. 534, pp. 123–127.
Suter, C.M. and Schuetz, R.D., Org. Chem., 1951, vol. 16, pp. 1117–1120.
Fuchs, A., Baur, R., Schoeder, C., Sigel, E., and Mueller, C.E., Bioorg. Med. Chem., 2014, vol. 22, pp. 6908–6917.
ACKNOWLEDGMENTS
The work was performed using the equipment of the Engineering Center of SPSTI (TU).
Funding
The work was supported by grant no. 17-04-02119 from the Russian Foundation of Basic Research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests
The authors declare that they have no conflict of interests.
Statement on the Welfare of Animals
All of the animal experiments were adhered to regulations of DIRECTIVE 2010/63/EU on the protection of animals used for scientific purposes and the guidelines of the Ethics Committee of Smorodintsev Research Institute of Influenza.
Additional information
Translated by A. Levina
Abbreviations: МН, 4'-О-methylhonokiol; СОХ, cyclooxygenase-2; LPS, lipopolysaccharide; brain WC, brain weight coefficient; HRMS(ESI), High resolution mass spectroscopy in the ESI mode.
Corresponding author: phone: +7 (921) 747-76-94; e-mail: gomzina@ihb.spb.ru.
Rights and permissions
About this article
Cite this article
Sivak, K.V., Stosman, K.I., Muzhikyan, A.A. et al. Evaluation of Antiinflammatory Activity of 4'-О-Methylhonokiol Derivatives in a Neuroinflammation Model. Russ J Bioorg Chem 45, 425–429 (2019). https://doi.org/10.1134/S1068162019040113
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162019040113